Medical and Scientific Director Block Center for Integrative Cancer Treatment Editor-In-Chief Integrative Cancer Therapies, Sage Science Press Editorial Board for Physician Data Query, Cancer CAM National Cancer Institute Director, Integrative Medic
Oncology
Dr. Keith I. Block, MD
Doctor Keith I. Block, MD practices Oncology. He attended University of Miami Miller School of Medicine. University of Miami Miller School of Medicine has a rank of 45 in research and a 0 in primary care Dr. Keith I. Block is a published physician. He published 85 publications, including: 'A nursing assessment standard for early intervention: family coping.' He accepts all Medicare patients.
Publications
- Designing a broad-spectrum integrative approach for cancer prevention and treatment.
- Integrative therapies in cancer: modulating a broad spectrum of targets for cancer management.
- Integrative Cancer Therapies. In this issue.
- In this issue: increasing impact of integrative cancer therapies.
- Integrating Dietary Supplements Into Cancer Care.
- Significance of natural product interactions in oncology.
- Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE(2) and PGE(3) and Alteration of Akt Phosphorylation.
- Prognostic Proof and Possible Therapeutic Mechanisms of Herbal Medicine in Patients With Metastatic Lung and Colon Cancer.
- A sad good-bye.
- Systems Modeling in Integrative Oncology.
- Cost savings with clinical solutions: the impact of reforming health and health care economics with integrative therapies.
- Making circadian cancer therapy practical.
- In this issue: circadian disruption and cancer.
- Response to 'Probable hepatotoxicity related to Nerium oleander extract in a patient with metastatic synovial sarcoma of the knee'.
- Could integrative cancer treatment be cost-saving and resuscitate a submerged medical system?
- Survival impact of integrative cancer care in advanced metastatic breast cancer.
- Prostate specific antigen screening.
- Antioxidants: SELECTed out?
- Enzymes and cancer: a look toward the past as we move forward.
- Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials.
- Feel better. Live better. Get better.
- An antioxidant turnabout.
- Cancer's impact on social roles.
- Cardiac glycosides as novel cancer therapeutic agents.
- On models for integrative medical practice.
- A step in the right direction.
- Editorial: just in cases...
- Integrative tumor board: metastatic breast cancer.
- "Top of the hierarchy" evidence for integrative medicine: what are the best strategies?
- Preadministration of high-dose salicylates, suppressors of NF-kappaB activation, may increase the chemosensitivity of many cancers: an example of proapoptotic signal m...
- Cancer, the mind, and the problem of self-blame.
- A tale of 2 studies: diet and breast cancer.
- Toward a core nutraceutical program for cancer management.
- Integrative Tumor Board: cholangicocarcinoma.
- Why integrative therapies?
- Multifocal angiostatic therapy: an update.
- Antioxidants in the news.
- Commentary: the pharmacological antioxidant amifostine -- implications of recent research for integrative cancer care.
- Challenges of complementary and alternative medicine research.
- Recapturing the Patient's Voice.
- Integrative tumor board: transitional cell carcinoma of the bladder.
- The demise of the super-aspirins: an opportunity for integrative medicine?
- Inflammation, COX-2 inhibitors, and cancer.
- Antioxidants and cancer therapy: furthering the debate.
- Integrative tumor board: Recurrent lymphoma.
- Integrative tumor board: glioblastoma multiforme.
- Safety and efficacy of herbal sedatives in cancer care.
- The challenges of randomized trials in integrative cancer care.
- Optimal healing environments and integrative cancer therapy.
- Integrative tumor board: metastatic renal cell carcinoma: integrative physician's perspective.
- Antineoplastons and the challenges of research in integrative care.
- Point-counterpoint: using clinical trials for the evaluation of integrative cancer therapies.
- The role of optimal healing environments in patients undergoing cancer treatment: clinical research protocol guidelines.
- Immune system effects of echinacea, ginseng, and astragalus: a review.
- Multiple molecular targets in oncology and integrative care.
- Integrative tumor board: recurrent breast cancer or new primary? Integrative physician's perspective.
- Integrative tumor board: colon cancer with liver metastases: case presentation.
- Mega-dose vitamin and mineral therapy in breast cancer: a clinician's perspective.
- Vitamin C in alternative cancer treatment: historical background.
- Mega-dose vitamins and breast cancer.
- Integrative cancer care and the art of medicine.
- Integrative tumor board: recently diagnosed prostate cancer.
- Breaking bad news.
- Panax ginseng: a role in cancer therapy?
- Integrative tumor board: recurrence of ovarian cancer.
- Pain, depression, and fatigue in cancer.
- Point-counterpoint: the immune system in cancer.
- Integrative tumor board: recently diagnosed lung cancer.
- Editorial: Looking beyond the obvious.
- Integrative tumor board: Advanced breast cancer.
- Editorial: On psycho-oncology, lycopene and the Noni fruit.
- Point-counterpoint: soy intake for breast cancer patients.
- Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes.
- Integrative tumor board: Esophageal cancer.
- Editorial: Integrative cancer treatment in the 21st century.
- Chronomodulated chemotherapy: clinical value and possibilities for dissemination in the United States.
- Efficacy and safety of herbal stimulants and sedatives in sleep disorders.
- Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials.
- Herbal remedies: efficacy in controlling sleepiness and promoting sleep.
- Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
- Psychooncology and total survivorship.
- Do sociodemographic and disease-related variables influence benefit-finding in cancer patients?
- A nursing assessment standard for early intervention: family coping.
- Phosphorylation of the human ubiquitin-conjugating enzyme, CDC34, by casein kinase 2.
Schools
Roy J Lucille a Carver College Of Medicine At University Of Iowa
Illinois Masonic Med Center Advocate Health Care Chicago
Doctors Specialties
- Internal Medicine
- Oncology
Accepted Insurances
Education
-
Advocate Illinois Masonic Medical Center -
University of Miami Miller School of Medicine
Hospital
-
Swedish Covenant Hospital -
Presence Resurrection Medical Center
Drug Facts
| NPI NUMBER | 1538208764 | |
| NPPES Provider LastName | BLOCK | |
| NPPES Provider FirstName | KEITH | |
| NPPES Provider ZIPCode | 602013777 | |
| NPPES Provider State | IL | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 209.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538208764 |
| Last Name Of The Provider | BLOCK |
| First Name Of The Provider | KEITH |
| View All |
Similar Doctors
|
Dr. Andrew G. Brandmaier, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Valerie D. Goodrich, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James S. Grober, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Janardan D. Khandekar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muhamad Krad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Youmna Ahmed, MD |
|
|
Dr. Jason M. Razdik, MD |
|
Dr. Bruce E. Brockstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vivek Kaushal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sara E. Barnato, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Teresa A. Murray Law, MD
This Doctor is OpenDoctor Recommended.
|